Ziziphus jujuba and its main components, lupeol and betulinic acid, show promise in treating complications of metabolic syndrome, including diabetes, obesity, and hypertension.
The research assessed the properties of Ziziphus jujuba and its main bioactive agents, lupeol and betulinic acid, in relation to metabolic syndrome. Investigations focussed on their potential roles in glucose uptake enhancement, hepatic glucose synthesis reduction, insulin sensitivity improvement, and lipid profile modulation. Studies involved identifying the influence of these substances on key signaling pathways and insulin signaling proteins, as well as evaluating their anti-adipogenic effects and capacity to improve endothelial function.
Ziziphus jujuba and its constituents exhibited potential therapeutic benefits for metabolic syndrome by facilitating glucose uptake, reducing glucose synthesis, and improving insulin sensitivity. They also showed potential in moderating lipid synthesis and fat accumulation, demonstrating anti-fatty effects and a capacity to influence adipogenic enzymes and transcription factors. Moreover, these substances demonstrated enhanced endothelial function, reflecting positively on vascular health. These accumulative findings suggest promising potential for Z. jujuba, lupeol, and betulinic acid as natural treatments for metabolic syndrome complications.
